BackLBX Pharmacy Chain Joint Stock Company Overview
LBX Pharmacy Chain Joint Stock Company

LBX Pharmacy Chain Joint Stock Company Return on Equity

Valuation check: 603883.SS's ROE is 7.05%, below the sector sector average of 11.3%.

Get informed when a big investor buys or sells

+ Follow

ROE

7.05%

Return on Equity

7.05%

Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.

ROE (Comparison Companies)

Loading

ROE History

Loading

ROE Comparison

Loading

LBX Pharmacy Chain Joint Stock Company (603883.SS) FAQ

LBX Pharmacy Chain Joint Stock Company's return on equity stands at 7.05%. That is below the sector sector average of 11.3%. Stockcircle updates this page with the newest filings so you can track how the metric evolves quarter by quarter.

LBX Pharmacy Chain Joint Stock Company sits lower the its sector benchmark (11.3%) with a ROE of 7.05%. That is roughly 37.6% below the sector mean. Peer context matters because what looks expensive or cheap in absolute terms can be normal for the sector.

A ROE of 7.05% for LBX Pharmacy Chain Joint Stock Company means each unit of related capital or sales is generating that return rate. Higher is usually better for profitability metrics, but extremely high figures can reflect one-time items or thin equity bases. Review several years of data on this page before extrapolating.

The history chart shows how LBX Pharmacy Chain Joint Stock Company's ROE evolved across reporting periods, while the comparison chart places 603883.SS next to similar companies. Use both: a rising metric that still lags peers tells a different story than a rising metric that already leads the group. Growth charts, when available, highlight acceleration or slowdown.